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ovement through the endocytic pathway occurs
principally via a series of membrane fusion and
ﬁssion reactions that allow sorting of molecules to
be recycled from those to be degraded. Endosome fusion is
dependent on SNARE proteins, although the nature of the
proteins involved and their regulation has not been fully
elucidated. We found that the endosome-associated hepato-
cyte responsive serum phosphoprotein (Hrs) inhibited the
homotypic fusion of early endosomes. A region of Hrs
predicted to form a coiled coil required for binding the
Q-SNARE, SNAP-25, mimicked the inhibition of endosome
fusion produced by full-length Hrs, and was sufﬁcient for
endosome binding. SNAP-25, syntaxin 13, and VAMP2
M
 
were bound from rat brain membranes to the Hrs coiled-
coil domain. Syntaxin 13 inhibited early endosomal fusion
and botulinum toxin/E inhibition of early endosomal fusion
 
was reversed by addition of SNAP-25
 
(150–206)
 
, conﬁrming
a role for syntaxin 13, and establishing a role for SNAP-25
in endosomal fusion. Hrs inhibited formation of the syntaxin
13–SNAP-25–VAMP2 complex by displacing VAMP2
from the complex. These data suggest that SNAP-25 is a
 
receptor for Hrs on early endosomal membranes and that
the binding of Hrs to SNAP-25 on endosomal membranes
inhibits formation of a SNARE complex required for homo-
typic endosome fusion.
 
Introduction
 
Organelles within the endocytic pathway are dynamic
structures, resulting from continual rounds of fusion and
fission of newly internalized vesicles with preexisting structures,
initially the early endosome (Hopkins et al., 1985; Gruenberg
and Maxfield, 1995; Ward et al., 1995; Ullrich et al., 1996;
Gruenberg, 2001). The early endosome is a major decision
point in the endocytic pathway in which cargo is sorted for
transport to late endosomes for eventual degradation in the
lysosome or for recycling to the plasma membrane (Hopkins
et al., 1985; Gruenberg and Maxfield, 1995; Ward et al.,
1995; Gruenberg, 2001). The early endosome is actually
composed of at least two forms including the vacuolar or
tubulovesicular sorting endosome, containing EEA-1 and
rab 5, as well as the recycling endosome, containing rab 11
(Hopkins et al., 1985; Gorvel et al., 1991; Gruenberg and
Maxfield, 1995; Ward et al., 1995; Ullrich et al., 1996;
Trischler et al., 1999; Gruenberg, 2001). Recycling of cargo
to the plasma membrane can take place from both early
endosomal compartments as can transport to late endosomes
(Hopkins et al., 1985; Gorvel et al., 1991; Gruenberg and
Maxfield, 1995; Ward et al., 1995; Ullrich et al., 1996;
Trischler et al., 1999; Gruenberg, 2001). It is likely that a
combination of maturation and vesicular transport mechanisms
allows for tight control of the sorting, transport, and recycling
functions in the early endosomal compartment (Gruenberg
and Maxfield, 1995; Gruenberg, 2001).
Protein machinery is required to overcome the energy
barrier for fusion of biological membranes. Interactions
among proteins associated with donor membranes (e.g.,
VAMP–synaptobrevin) and acceptor membranes (e.g., syntaxin
and SNAP-25) are thought to be essential for fusion (Sutton
et al., 1998; Weber et al., 1998; Jahn and Sudhof, 1999;
Chen and Scheller, 2001). These proteins are known as
SNAREs (Sollner et al., 1993) and they are sufficient for
membrane fusion in artificial membranes, suggesting that
SNAREs are the core membrane fusion machinery (Weber
et al., 1998). Botulinum and tetanus toxins are zinc endo-
proteases that the SNAREs, thus, inhibiting the formation
of SNARE complexes, blocking fusion (Jahn and Sudhof,
1999; Lin and Scheller, 2000). The specificity of SNARE
protein complex formation is likely dependent on protein
localization and chaperone function (Jahn and Sudhof,
1999; Lin and Scheller, 2000; Chen and Scheller, 2001).
SNAREs form cytoplasmic coiled-coil bundles that bridge
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two membranes to enable membrane fusion, perhaps via tor-
sional forces produced during helical bundle formation that
may deform the lipid bilayer (Sutton et al., 1998; Jahn and
Sudhof, 1999; Chen and Scheller, 2001).
In vitro models of endosome fusion have been used to de-
fine the behavior of endosomal compartments after internal-
ization of cargo. These assays have led to an understanding
of some factors that influence the fate of internalized ligands
and receptors and what components are required for homo-
and heterotypic fusion (Braell, 1987, 1992; Diaz et al.,
1988; Salzman and Maxfield, 1988; Gruenberg et al., 1989;
Ward et al., 1989, 1990, 1997, 2000; Gorvel et al., 1991;
Mullock et al., 2000). Endosomes and lysosomes can un-
dergo homotypic fusion (e.g., early endosome with early en-
dosome) and sequential compartments can fuse (e.g., early
endosome with late endosome), although nonsequential
compartments cannot (e.g., early endosomes do not fuse
with lysosomes; Braell, 1987; Diaz et al., 1988; Salzman and
Maxfield, 1988; Gruenberg et al., 1989; Ward et al., 1990,
1997; Mullock et al., 2000). These fusion reactions are de-
pendent on SNARE proteins residing on the appropriate
compartment (Prekeris et al., 1998, 1999; Mullock et al.,
2000; Ward et al., 2000). For example, syntaxin 13 is found
on early endosomes and a soluble fragment of syntaxin 13
inhibits homotypic early endosome fusion (Prekeris et al.,
1998; McBride et al., 1999) without affecting homotypic ly-
sosome fusion, whereas a soluble fragment of syntaxin 7,
which is present on late endosome–lysosome membranes,
inhibits homotypic lysosome fusion but not early endosome
fusion (Ward et al., 2000). Thus, endosome fusion is depen-
dent on SNARE protein complexes and is restricted, allow-
ing orderly modification of ligand–receptor complexes and
signaling in a sequential manner by altering the milieu (e.g.,
pH) in successive compartments.
Hepatocyte responsive serum phosphoprotein (Hrs)* is a
mammalian protein predominantly localized on early endo-
somes (Komada et al., 1997; Tsujimoto et al., 1999). Hrs
physically interacts with a number of proteins, including
eps15 (Bean et al., 2000), SNX-1 (Chin et al., 2001), and
SNAP-25 (Bean et al., 1997) that have been previously im-
plicated in membrane trafficking. Hrs has homologues in fly
(Lloyd et al., 2002) and yeast (Raymond et al., 1992). Dele-
tion or mutation of Hrs results in an enlarged endosomal
phenotype in mouse (Komada and Soriano, 1999), fly
(Lloyd et al., 2002), and yeast (Raymond et al., 1992) with-
out an obvious defect in lysosomal trafficking (e.g., the ab-
sence of Hrs does not result in increased expression of
plasma membrane proteins and internalized proteins can be
transported to lysosomes), suggesting that Hrs may affect
endosome fusion.
Endocytosis of the EGF receptor (EGFR) is initiated by the
binding of its ligand, EGF (Honegger et al., 1990; Barbieri et
al., 2000; Carpenter, 2000; Burke et al., 2001; Schlessinger,
2002). The EGFR-ligand complex is transported through the
endocytic pathway where a choice about its fate, whether to
be recycled or degraded, is made. The EGFR-ligand complex
is then either recycled back to the cell surface or moves to late
endosomes, and ultimately, the lysosome for degradation
(Honegger et al., 1990; Barbieri et al., 2000; Carpenter,
2000; Burke et al., 2001). We have taken advantage of the
well-characterized trafficking of the EGF–EGFR complex,
the dependence of EGF receptor endocytosis on ligand bind-
ing, and previously developed cell-free endosome fusion as-
says, to develop a novel approach for measuring fusion of
EGF–EGFR-containing compartments. By allowing different
populations of HeLa cells to engage in receptor-mediated en-
docytosis of EGF linked to either Alexa
 
488
 
 or tetramethyl-
rhodamine (TMR), we are able to isolate donor and acceptor
pools of endosomes and lysosomes. These compartments are
used in fusion reactions that are analyzed by examining reso-
nance energy transfer between the fluorophores to detect con-
tent mixing. This assay is dependent on temperature, time,
energy, and cytosol. We have used our newly developed endo-
some fusion assay to examine the effect of Hrs on fusion of
different populations of endosomal membranes. We observed
that Hrs selectively inhibits the homotypic fusion of early en-
dosomes and that the coiled-coil region of the protein medi-
ates this effect as well as its endosomal membrane association.
We determined that SNAP-25 is an endosomal receptor for
Hrs, and that Hrs inhibits the formation of the early endoso-
mal SNARE complex consisting of SNAP-25, syntaxin 13,
and VAMP2, suggesting a mechanism by which Hrs inhibits
early endosome fusion.
 
Results
 
A novel fluorescence resonance energy transfer 
(FRET)-based homotypic membrane fusion assay
 
We have taken advantage of the trafficking pattern of EGF–
EGFR complexes and the dimerization of EGFR to design a
cell-free assay to detect endosome fusion. By allowing differ-
ent populations of HeLa cells to engage in receptor-mediated
endocytosis of EGF linked to either Alexa
 
488
 
 or TMR for vari-
ous times, we are able to isolate donor and acceptor pools of
endocytic intermediates. These compartments are used in fu-
sion reactions analyzed by measuring resonance energy trans-
fer between the fluorophores to detect content mixing.
After increasing periods of chase time EGF-TMR–labeled
cells were immunolabeled with markers for the early en-
dosome (EEA-1), late endosome (rab 7), and lysosome
(LAMP1/2). By quantifying the amount of overlap between
the two signals we generated a time course of EGF-TMR
movement through the endocytic pathway that we used as
the optimal labeling time for the various compartments.
When HeLa cells are incubated with EGF-TMR for 15 min,
the predominant localization of the EGF-TMR labeling was
in an EEA-1–positive structure, putatively an early endo-
some (Fig. 1, A and B). If HeLa cells were labeled with a
15-min pulse of EGF-TMR, washed, and incubated in nor-
mal media for increasing incubation times the EGF-TMR
moved from the early endosome to the late endosome (Fig.
1 C) and the lysosome (Fig. 1 D), as identified by colocaliza-
tion of the EGF-TMR with markers for those compartments
(rab 7 and LAMP 1/2, respectively).
 
*Abbreviations used in this paper: BoNT/E, botulinum neurotoxin E;
DMEM, Dulbecco’s minimum essential medium; EGFR, EGF receptor;
FRET, fluorescence resonance energy transfer; Hrs, hepatocyte responsive
serumphosphoprotein; TMR, tetramethylrhodamine; UIM, ubiquitin
interacting motif.T
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To better understand the fate of EGF in our cells, we have
examined the percentage of 
 
125
 
I-EGF that is recycled, de-
graded, or within HeLa cells after a pulse of EGF. The
amount of EGF recycled after a 15-min pulse is 
 
 
 
5–7% of
the total cellular EGF, the amount degraded in 15 min is
 
 
 
5% of the total, and the amount within the cells is 
 
 
 
90%
of the total cellular EGF (unpublished data). These data are
consistent with many reports in the literature for HeLa cells
(Satin et al., 1997; Futter et al., 2001). The kinetics we have
observed for ligand internalization is very similar to those for
labeled EGFR internalization (Burke et al., 2001). Here, the
movement of internalized labeled EGFR was examined in
relation to its localization in the EEA-1 positive early endo-
some. The maximal colocalization of labeled receptor with
EEA-1 occurred at 15 min after initiation of internalization.
These data suggest that in HeLa cells the kinetics we have
observed are consistent with many previously published re-
ports for ligand and receptor internalization and trafficking
to early endosomes. Moreover, very little of the ligand is be-
ing recycled or degraded at the time the endosomes are iso-
lated and, therefore, the contribution of these steps to the
fusion observed is likely minimal.
Based on the optimal labeling conditions for each com-
partment (Fig. 1), fluorescently labeled early and late endo-
somal populations, as well as lysosomes, were isolated and
used in fusion reactions. In the absence of donor or acceptor
membranes, ATP, or cytosol, compartment fusion did not
occur as visualized because of a lack of a TMR emission sig-
nal (580 nm) that is significantly above baseline after excita-
tion of the Alexa fluorophore at 495 nm (Fig. 2 A). These
fusion reactions were also temperature dependent, as incu-
bation at 0
 
 
 
C also resulted in a lack of TMR emission signal
(Fig. 2 A). The fusion signal requires intact membranes be-
cause incubation of completed reactions with 1% Triton
X-100 resulted in a signal that was not significantly different
from the background (unpublished data). The fusion signal
we observe is not likely due to the contribution of extra en-
dosomal receptors because acid washing the plasma mem-
brane before cell homogenization coupled with the addition
of unlabeled EGF (300 
 
 
 
g/ml) to the reactions did not al-
ter the fusion-induced FRET signal (unpublished data).
The energy transfer observed was either the result of het-
erodimerization of EGFRs that have bound EGF containing
Alexa
 
488
 
 and TMR or the exchange of differently tagged
ligands on dimerized receptors (Schlessinger, 2002). We
think it more likely that receptor heterodimerization is the
mechanism because heterodimerization of EGFRs is known
to occur in the plane of the plasma membrane (Muth-
uswamy et al., 1999; Wang et al., 1999; Saito et al., 2001).
Moreover, EGF is generally thought to be stably associated
with its receptor throughout the endocytic pathway, perhaps
due to its high affinity (Futter et al., 1996). This would im-
ply that after fusion of the endosomal membranes the
ligands remain bound and the receptors can exchange part-
ners, although receptor–receptor and receptor–ligand inter-
actions are highly dynamic and it is not possible to distin-
guish among these possibilities within the scope of these
studies. The FRET signal was not likely due to a high con-
centration of both fluorophores in the small volume of the
endosome because as the fusion reactions progress the size of
the fused compartment increases and the FRET signal did
not decrease in proportion to the size of the fused compart-
ment (unpublished data). Moreover, if donor compartments
were labeled with EGF-Alexa
 
488
 
 and the acceptor compart-
ments were labeled by internalization of transferrin-TMR,
no FRET signal significantly above background was ob-
tained after a fusion reaction, which is consistent with the
inability of EGF and transferrin receptors to dimerize (Fig. 2
B). Transferrin-TMR was localized in an EEA-1–positive
compartment under these conditions in HeLa cells (unpub-
lished data). Optimal fusion time was determined by exam-
ining the extent of fusion after incubating the reactions for
various amounts of time at 37
 
 
 
C. After 20 min of incuba-
Figure 1. EGF is transported through endocytic compartments 
after internalization. (A) Colocalization of early endosomes with 
EGF-TMR in HeLa cells. The distribution of EEA1 (A, green), EGF-TMR 
(B, red), and the merged images (C) shows colocalization of EEA1-
labeled early endosomes and EGF-TMR. (B) Percentage of EEA1-
labeled early endosomes colocalized with EGF-TMR–containing 
vesicles after various incubation times. (C) Percentage of rab
7–labeled late endosomes colocalized with EGF-TMR–containing 
vesicles at various chase times after a 15-min pulse of EGF-TMR. 
(D) Percentage of LAMP 1/2–labeled lysosomes colocalized with 
EGF-TMR–containing vesicles at various chase times after a 15-min 
pulse of EGF-TMR. The error bars in B–D show SEM. Bar, 8  m. T
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tion, fusion was 
 
 
 
50% of the maximum and the amount of
fusion increased until 60 min of incubation, after which no
further significant increase in fusion was observed (Fig. 2 C).
Therefore, the 60-min time point was chosen as the optimal
fusion time for the assay.
To test the effect of membrane dilution, the reaction vol-
ume was increased to dilute the concentration of donor/ac-
ceptor membranes while the concentration of ATP and cy-
tosol was maintained at a constant level. A decrease in FRET
signal was observed concomitant with an incremental in-
crease in the reaction volume (Fig. 2 D). This suggests that
the concentration of donor and acceptor membranes has a
critical threshold for optimal reconstitution of homotypic
endosome fusion.
As a further confirmation that these fusion reactions are
SNARE dependent and comparable to what has been previ-
ously observed in the literature (Prekeris et al., 1998, 1999;
McBride et al., 1999; Ward et al., 2000), we examined the
effect of the soluble fragments of syntaxin 13 and 7 on fu-
sion of early and late endosomes as well as lysosomes (Fig. 2
E). The soluble syntaxin 13 protein specifically inhibited
early endosome fusion (Fig. 2 E) with no effect on late endo-
some or lysosome fusion (not depicted). The soluble syn-
taxin 7 protein specifically inhibited lysosome fusion (Fig. 2
E) with no effect of early or late endosome fusion (not de-
picted). As an additional control, we examined the effect of
wild-type and mutant rab 15, a small GTPase that has been
previously implicated as a regulator of early endosome fu-
sion (Zuk and Elferink, 1999). Addition of lysate from cells
overexpressing wild-type rab 15 significantly inhibited early,
but not late, endosome fusion 46 
 
 
 
 4% (
 
n 
 
  
 
3, P 
 
  
 
0.05),
whereas the Q67L mutant inhibited early endosome fusion
by 65.6 
 
 
 
 4% (
 
n 
 
  
 
3, P 
 
  
 
0.05), which is consistent with
previously published data (Zuk and Elferink, 1999).
Ultrastructural examination of the morphology of donor/
acceptor membranes before a fusion reaction revealed the
presence of consistently sized membrane-bound compart-
ments (mean diameter, 58.3 
 
  
 
1.7 nm; Fig. 3 A), the major-
ity of which were uncoated although an apparently clathrin-
coated vesicle can be observed occasionally (Fig. 3 A). After
fusion reactions, the mean diameter of membrane compart-
ments was significantly enlarged to 188.5 
 
 
 
 7.3 nm (P 
 
 
Figure 2. Characterization of a FRET-based assay measuring homotypic compartment fusion. (A) Fusion reactions were performed without 
the indicated component or on ice (0 C) to assess requirements for the reaction. There are significant differences between the complete homotypic 
fusion reactions and all other conditions in which a component has been omitted or altered (*, P   0.001) by ANOVA and Fisher test. Raw 
data after background subtraction are as follows. Early endosome fusion: no donor, 14.1   3.5; no acceptor, 15.4   5.0; no ATP, 37.3   16.0; 
no cytosol, 28.3   3.6; ice, 10.7   4.3; and complete homotypic reaction, 302.5   7.7. Late endosome fusion: no donor, 16.3   3.4; no 
acceptor, 13.1   12.8; no ATP, 15.6   10.8; no cytosol, 26.6   7.8; ice, 12.8   4.8; and complete homotypic reaction, 312.1   6.3. Lysosome 
fusion: no donor, 28.4   1.4; no acceptor, 21.0   6.2; no ATP, 23.9   8.2; no cytosol, 24.3   7.0; ice, 13.3   1.2; and complete homotypic 
reaction, 325.3   16.0. (B) Energy transfer is dependent on EGF-labeled donor and acceptor membranes. When both fluorescent tags are 
present on EGF and endosomes are labeled and fused a FRET signal occurs. However, labeling the acceptor population of endosomes with 
transferrin-TMR reduces the FRET signal to background levels (*, P   0.01). The error bars show SEM. (C) The optimal incubation time for 
fusion reactions was determined by examining the extent of fusion after incubating the reactions for various amounts of time at 37 C. The 
amount of fusion increased until 60 min of incubation, after which no further significant increase in fusion is observed. (D) The fusion reaction 
volume was increased to dilute the concentration of donor/acceptor membranes while the concentrations of ATP and cytosol were maintained 
at a constant level. A decrease in FRET signal was observed concomitant with an incremental increase in the reaction volume. (E) Syntaxin 13 
and 7 affect homotypic endosome fusion. Syntaxin 13 inhibited early endosome homotypic fusion. Syntaxin 7 inhibited homotypic lysosome 
fusion. These data are consistent with previously published reports (see Introduction and Results). *, P   0.01.T
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0.05). Compartments containing membrane as well as
membranes apparently docked and/or undergoing fusion
could also be observed (Fig. 3, B and C).
 
Hrs inhibits homotypic fusion of early endosomes
 
We examined the effect of the Hrs protein on the three dif-
ferent homotypic fusion reactions. Hrs specifically inhib-
ited early endosome fusion with no effect on late endosome
or lysosome fusion (Fig. 4 A). The inhibition of early endo-
some fusion by recombinant Hrs was concentration depen-
dent and saturable with half-maximal inhibition observed
at 
 
 
 
30 nM. The total level of Hrs in HeLa cells is 
 
 
 
2-4 
 
 
 
10
 
 
 
5 
 
 
 
g/cell. If the volume of a HeLa cell is 
 
 
 
4 nl (an av-
erage size for HeLa cells is 15–20 
 
 
 
m in diameter for a sus-
pended cell and, therefore, its volume 4/3
 
 
 
r
 
3
 
 
 
  
 
4,000
mm
 
3
 
 or 4 
 
 
 
 10
 
 
 
9
 
 cm
 
3
 
), and the rough estimation of a cyto-
solic intracellular Hrs concentration would be 0.5–1 nM.
The Hrs present in these cells is roughly 75% cytosolic and
25% membrane associated. Moreover, the localization of
Hrs on endosomal membranes is patchy (Tsujimoto et al.,
1999; Urbe et al., 2000; Raiborg et al., 2001a, 2002) with
areas of apparently much higher concentration. Thus, it is
very difficult to determine the local concentration of Hrs
on the endosomal membrane and, therefore, what would
be the physiologically relevant concentrations of Hrs for
endosome fusion. We have observed a dose-dependent and
saturable effect whose half-maximal value is 
 
 
 
30 nM and
that saturates at 
 
 
 
100 nM. Given the caveats presented
above, we believe this to be within the physiologically rele-
vant range for the concentration of Hrs on the endosomal
membrane. Hrs was required for an early event in the fu-
sion reaction because the inhibition produced by Hrs was
maximal if added within 10 min after the initiation of the
reaction and diminished if Hrs was added after that time
(Fig. 4 B). To examine the effect of Hrs depletion on early
endosome fusion, we treated HeLa cells with RNAi du-
plexes targeted against Hrs in addition to immunodeplet-
ing Hrs from the cytosol. After treatment, Hrs was un-
detectable in whole cell lysates from which the donor/
acceptor endosomes were isolated, as well as in the rat brain
cytosol required for the assay. Under these conditions we
observed a significant (P 
 
  
 
0.05), albeit modest, 16 
 
 
 
 4%
increase in endosome fusion, whereas the controls lacking
cytosol or transfected with scrambled RNAi duplexes were
not significantly different than the homotypic reaction
(unpublished data).
To understand the mechanism by which Hrs inhibited
early endosome fusion, we examined the effect of different
domains of Hrs to determine whether a minimal fragment
of Hrs was required for the effect. We examined a large
NH
 
2
 
-terminal fragment of Hrs that contains the VHS,
FYVE, and UIM domains, as well as the binding sites for
eps15 (Bean et al., 2000) and STAM (Asao et al., 1997; Fig.
5 A). This domain did not significantly alter early endosome
fusion (Fig. 5 B). However, a region of Hrs containing ei-
ther both (Hrs
 
449–562
 
) or just the second coiled-coil domain
(Hrs
 
515–562
 
) inhibited early endosome fusion with concentra-
tion dependence and saturability that was indistinguishable
from the full-length protein (Fig. 5 C).
Figure 3. Morphology of endosomal membranes before and after 
fusion reactions. Membranes were obtained as described for homo-
typic reactions of early endosomes (see Materials and methods) and 
fixed in 3% glutaraldehyde (A, donor) or after incubation with acceptor 
membranes, cytosol, and ATP regenerating system (B, after fusion). 
The diameter of all membrane bound profiles was measured on images 
from donor and fused samples (C). The mean diameter of donor 
compartments was 58.3   1.7 nm (n   123) and postfusion com-
partment diameter was 188.5   7.3 nm (n   96; *, P   0.0001). 
The error bars show SEM. Bars: (A and B) 100 nm.
Figure 4. Hrs inhibits early endosome fusion at an early stage 
in the fusion reaction. (A) Hrs inhibits early endosome fusion in a 
dose-dependent and saturable manner (diamond), without having 
a significant effect on late endosome (square) or lysosome (triangle). 
(B) Hrs-induced inhibition of early endosome fusion occurs most 
prominently when Hrs is added to the reactions within the first 10 
min of incubation. If Hrs is added after the first 10 min of the fusion 
reaction, its ability to inhibit the reaction reduced.T
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Hrs binds to SNAP-25 on early endosomal membranes
 
To determine whether Hrs might exert its effect by binding
to endosomal membranes, we incubated purified endosomes
with increasing concentrations of recombinant Hrs (Fig. 6
A). We observed saturable binding of Hrs to EEA-1–positive
early endosomes, suggesting that a finite number of binding
sites were present on this membrane. Moreover, SNAP-
25
 
(150–206)
 
 inhibited the binding of Hrs to endosomal mem-
branes (Fig. 6 B) suggesting that the Hrs–SNAP-25 interac-
tion is responsible for endosomal binding of Hrs and that
SNAP-25 is the endosomal Hrs receptor. We also observed
that the coiled-coil domain Hrs
 
449–562
 
 itself bound to endo-
somal membranes (Fig. 6 C). The binding of either Hrs or
Hrs
 
449–562
 
 was 80% complete after incubation with endoso-
mal membranes for 15 min at 0
 
 
 
C (unpublished data).
Because Hrs bound saturably to endosomal membranes
and this binding was inhibited by SNAP-25
 
(150–206)
 
, we hy-
pothesized the presence of a membrane receptor whose iden-
tity was likely SNAP-25. To identify potential membrane
receptors, affinity chromatography was performed using im-
mobilized Hrs
 
449–562
 
 on a detergent-extracted rat brain mem-
brane fraction. We detected SNAP-25, syntaxin13, and
VAMP2 after salt elution from the affinity column, whereas
none of these proteins were detected in the eluate from a
control (GST) column (Fig. 7). Neither SV2, eps15, synap-
totagmin, synaptophysin, synapsin, syntaxin 6 (Fig. 7), rab
5, rab 15, nor EEA-1 (not depicted) were detected in the
eluate from the affinity column. Because Hrs does not di-
rectly bind to VAMP or syntaxin (Tsujimoto and Bean,
2000), these data further suggested that the endosomal Hrs
receptor is SNAP-25. This was consistent with the direct in-
teraction of Hrs with SNAP-25 (Bean et al., 1997).
 
Hrs prevents the formation of a SNARE complex 
on early endosomes
 
Because we detected a SNAP-25–containing SNARE com-
plex on endosomal membranes, we examined the effect of
botulinum neurotoxin E (BoNT/E), a zinc endoprotease
Figure 5. Determination of the domain of Hrs required for the 
inhibition of early endosome fusion. (A) The linear structure of Hrs 
highlighting some protein motifs. (B) The NH2-terminal half of Hrs, 
including the VHS and FYVE domains, had no effect on early endo-
some fusion. (C) Although both helical domains of Hrs inhibit early 
endosome fusion with similar efficacy to the full-length protein, the 
minimal fragment of Hrs that is both necessary and sufficient for the 
recapitulation of the inhibition of early endosome fusion observed 
with full-length Hrs is the Q-SNARE domain Hrs(515–562).
Figure 6. Hrs binds saturably to early endosomal membranes. 
Hrs and Hrs(449–562) bind to early endosomal membranes. Early 
endosomes were purified on a discontinuous sucrose gradient and 
contain the marker protein EEA-1. Full-length Hrs binds saturably 
to early endosomal membranes (A). SNAP-25(150–206) inhibited the 
binding of Hrs to endosomal membranes (B). Hrs(449–562) also binds 
to endosomal membranes (C), suggesting that the coiled-coil domain 
of Hrs is sufficient for endosomal membrane binding. Hrs or Hrs(449–562) 
is not found in the pellet in the absence of membranes.
Figure 7. Affinity chromatography 
of brain membranes using immobilized 
Hrs(449–562). A SNARE complex consisting 
of syntaxin 13, SNAP-25, and VAMP2 
has been previously reported to be 
present on early endosomal membranes 
(Prekeris et al., 1998). Hrs has been 
previously reported to bind to SNAP-25 
(Bean et al., 1997) requiring aa 515–562 
(Tsujimoto and Bean, 2000). Candidate 
proteins were examined by Western 
analysis on blots obtained from the affinity 
column eluate. SNAP-25, syntaxin 13, 
and VAMP2 bound to the column, 
whereas SV2, eps15, synaptophysin, 
synaptotagmin, synapsin, syntaxin 6, and 
rab 5, rab 15, and EEA-1 (not depicted) 
did not bind to Hrs (449–562).T
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that cleaves the COOH-terminal 26 aa of SNAP-25.
BoNT/E blocks membrane fusion that requires a four-heli-
cal–SNARE complex containing SNAP-25 (Banerjee et al.,
1996; Chen et al., 1999; Jahn and Sudhof, 1999). We ob-
served that BoNT/E inhibited early endosome fusion in a
concentration-dependent manner with a half-maximal inhi-
bition of 
 
 
 
20 nM (Fig. 8 A). Moreover, the addition of
SNAP-25
 
(150–206)
 
 completely reversed the inhibition of fu-
sion produced by BoNT/E (Fig. 8 B). These results suggest a
previously unappreciated role for SNAP-25 in early endo-
some fusion.
To understand how Hrs might inhibit early endosome fu-
sion, we examined the in vitro formation of an early endoso-
mal 7S fusion complex containing syntaxin 13, SNAP-25,
and VAMP2. Using immobilized syntaxin 13, we formed
the 7S complex with SNAP-25 and VAMP2 (Fig. 9, lane 1).
Increasing concentrations of Hrs inhibited the amount of
VAMP2 inclusion in the 7S complex (Fig. 9). At saturating
concentrations, Hrs completely inhibited VAMP from bind-
ing to the complex. These results suggested that Hrs could
inhibit the formation of the 7S fusion complex by binding
to SNAP-25, inhibiting VAMP incorporation into the com-
plex (Fig. 10).
 
Discussion
We have shown that the Hrs protein specifically inhibits the
homotypic fusion of early endosomes while having no effect
on late endosome or lysosome fusion. Moreover, the coiled-
coil region of Hrs binds to early endosomal membranes and
is necessary and sufficient for the inhibition of endosome fu-
sion. To identify a membrane receptor for Hrs, the coiled-
coil region of Hrs was used to isolate proteins from rat brain
membranes and identified a SNARE complex (SNAP-25,
syntaxin 13, and VAMP2) thought to be present on early
endosomes. The inhibition of early endosome fusion by
BoNT/E and the rescue of that effect by the COOH-termi-
nal coiled-coil region of SNAP-25, establishes a role for
SNAP-25 in endosome fusion. Hrs inhibits the formation of
the early endosome 7S SNARE complex, suggesting a mech-
anism by which Hrs inhibits early endosome fusion (Fig.
10). These data suggest a negative role for Hrs on endosome
fusion that is mediated by its binding to SNAP-25 on endo-
somal membranes. The increase in endosome size observed
after deletion of Hrs (Raymond et al., 1992; Komada and
Soriano, 1999; Lloyd et al., 2002) is consistent with this ob-
servation.
By allowing different populations of HeLa cells to engage
in receptor-mediated endocytosis of EGF linked to either
Alexa488 or TMR, we are able to isolate donor and acceptor
Figure 8. BoNT/E inhibits early endosomal fusion in a 
SNAP-25(150–206)–dependent manner. (A) BoNT/E dose dependently 
and saturably inhibited early endosome fusion. (B) The inhibition 
of early endosome fusion by BoNT/E is reversed by addition of 
SNAP-25(150–206) supporting a role for SNAP-25 in endosome fusion.
Figure 9. Hrs decreases the efficiency of early endosomal 
syntaxin13–SNAP-25–VAMP2 complex formation. Quantitation 
of the amount of Hrs (A, expressed in optical density units) or VAMP 
(B, expressed as a percentage of VAMP incorporated in the absence 
of Hrs) incorporated into the 7 S complex in the presence of increasing 
amounts of Hrs is shown. (C) Glutathione-immobilized GST or 
GST–syntaxin 13, SNAP-25, and VAMP2 were incubated in the 
absence (lane 1) and presence of increasing amounts of Hrs. 
Samples were processed, and immunoblots were visualized with 
125I-secondary antibodies and phosphorimaging.T
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pools of EGF-containing endosomes. These compartments
were then used in fusion reactions that are analyzed by mea-
suring resonance energy transfer between the fluorophores
to detect content mixing. The ability to examine the fusion
of compartments in which EGF–EGFR complexes reside, as
well as the relative ease of measurement of the fusion signal,
are advantages of this assay over previously developed fu-
sion assays using immunoprecipitation of enzyme–substrate
complexes (Gruenberg et al., 1989; Ward et al., 1990, 1997;
Braell, 1992).
Hrs has been suggested to be involved in both exocytosis
and endocytosis. Data implicating Hrs in exocytosis are that
it binds to a protein, SNAP-25, that is essential for neu-
rotransmitter secretion, and that the recombinant protein
inhibits neurotransmitter secretion (Bean et al., 1997; Murai
and Kitamura, 2000). However, the preponderance of evi-
dence suggests that the Hrs protein is involved in endocyto-
sis because it is localized on endosomal membranes (Ko-
mada et al., 1997; Tsujimoto et al., 1999), it interacts with
proteins implicated in endocytosis (Bean et al., 2000; Chin
et al., 2001), and it has homology with a yeast protein
(Vps27p) required for endocytic protein sorting (Raymond
et al., 1992; Komada and Kitamura, 1995). The effect of
Hrs on secretion may result from promiscuous binding of
Hrs to the 7S complex formed between the Golgi-derived
secretory vesicle and the plasma membrane resulting from
the mistargeting of the exogenously added or highly overex-
pressed Hrs.
The mouse knockout of Hrs is embryonic lethal and the
only observable phenotype is the presence of enlarged early
endosomes (Komada and Soriano, 1999). The Drosophila
knockout also possesses enlarged endosomes (Lloyd et al.,
2002). The yeast homologue of Hrs is likely Vps27p, whose
mutant phenotype is the presence of an enlarged “class E,”
presumed prevacuolar/endosomal compartment (Raymond
et al., 1992). A common thread among these phenotypes is
the presence of an enlarged endosomal compartment and
the hypothesis suggested to explain them is the inhibition of
a sorting or trafficking step before the lysosome. In mamma-
lian cells, the predominant localization of Hrs is on early en-
dosomes, although a small percentage is found on the limit-
ing membrane of late endosomes (Komada et al., 1997;
Tsujimoto et al., 1999). The enlargement of early endo-
somes in mammalian cells suggests either an inhibition of
trafficking out of these structures, an increase in the fusion
of transport vesicles with early endosomes, or an increase in
the homotypic fusion of early endosomes. We directly
showed that Hrs inhibits the homotypic fusion of early en-
dosomes. These data are consistent with a negative role of
Hrs on early endosome fusion that would be absent in a null
mutant. The adventitious expression of Hrs also produces an
enlarged endosomal compartment in mammalian cells that
appears similar to the null phenotype and is likely the result
of a complex interaction of the binding and sequestration of
the many Hrs binding partners due to its overexpression.
The deletion of Hrs from mouse and fly results in enlarged
early endosomes and, although the removal of the protein
has its own limitations, the overexpression manipulation
may provide less clarity due to the varied phenotypes ob-
served with varying levels of expression (e.g., Raiborg et al.,
2001a) that may be due to binding partner affinities or alter-
ations in cellular localization.
The exact domain of Hrs required for membrane associa-
tion has been unclear. For example, Komada et al. (1997)
and Hayakawa and Kitamura (2000) have shown that dele-
tion of the FYVE domain does not alter the membrane/
endosomal localization of overexpressed Hrs. Urbe et al.
(2000) have shown that overexpression of FYVE domain de-
letions results in a cytosolic localization and suggest that
FYVE–PI3-P interactions cooperate with a second interac-
tion domain located elsewhere in the protein to specify its
membrane localization. Raiborg et al. (2001b) have sug-
gested that the FYVE domain, in cooperation with the
coiled-coil domain, contributes to the targeting of Hrs to
endosomes. The difference between our work and the previ-
ously published work is that in the previous studies, the role
of different domains in membrane association was deter-
mined by overexpression of Hrs or fragments. Potential mis-
localization due to overexpression or oligomerization of frag-
ments with the endogenous protein may be factors in the
localization of various overexpressed fragments. The binding
of purified Hrs protein to purified EEA-1–positive early en-
dosomes shows that Hrs or Hrs(449–562) can bind rapidly and
in a saturable manner to early endosomal membranes. These
data suggest that the coiled-coil domain of Hrs can bind to
endosomal membranes in the absence of other domains and
Figure 10. Model for the mechanism by which Hrs inhibits early 
endosome fusion. (A) Pairing of SNAREs (VAMP2, SNAP-25, and syn-
taxin 13) from opposing membranes results in helical bundle formation 
required for membrane fusion. (B) Hrs inhibits early endosome fusion 
by preventing SNARE complex formation. Hrs binds to SNAP-25 using 
its Q-SNARE–containing second coiled coil and inhibits VAMP2 from 
binding to the SNAP-25–syntaxin13 complex. N, NH2; C, COOH.T
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that Hrs binds to a finite number of binding sites, thus im-
plicating a membrane receptor. SNAP-25 is the likely mem-
brane receptor as the region of SNAP-25 responsible for Hrs
binding was able to completely inhibit the endosomal bind-
ing of Hrs, and the coiled-coil region of Hrs affinity isolated
a SNAP-25 containing SNARE complex from brain mem-
branes. Additionally, association of Hrs with endosomal
membranes, even when the binding is performed at 0 C,
suggests a high affinity interaction and rapid association
rate. The domain of Hrs necessary and sufficient for the in-
hibition of early endosome fusion is the coiled-coil domain
previously shown to be responsible for binding SNAP-25/23
(Tsujimoto et al., 1999; Tsujimoto and Bean, 2000). The
NH2-terminal region of Hrs containing the VHS and FYVE
domains, as well as the eps15 (Bean et al., 2000) and STAM
(Asao et al., 1997) binding sites, are not required for the in-
hibition of early endosome fusion, suggesting that activities
ascribed to these domains are unrelated to endosome fusion
and may be the basis for other functions of the Hrs protein.
An early endosomal SNARE complex has been purified
using a syntaxin 13 affinity column that contains SNAP-25
and VAMP2 (Prekeris et al., 1998). Here, syntaxin 13 was
localized to the tubulovesicular structures of early endo-
somes and shown to be present in a complex with  SNAP,
VAMP 2/3, and SNAP-25 that binds  SNAP and NSF and
dissociates in the presence of ATP, but not ATP S (Prekeris
et al., 1998). Soluble fragments of syntaxin 13 or antibodies
against syntaxin 13 inhibit endosome fusion, suggesting that
its cognate SNARE complex is involved in early endosome
fusion (Prekeris et al., 1998; McBride et al., 1999). Using a
recombinant Hrs(449–562) affinity column, we isolated SNAP-
25, syntaxin 13, and small amounts of VAMP2. Hrs does
not bind to either syntaxin 13 (unpublished observations)
or VAMP2 (Tsujimoto and Bean, 2000), suggesting that
Hrs(449–562) binds to SNAP-25 in this complex. These data
suggest that Hrs binds to this early endosomal SNARE com-
plex and competes with VAMP2 for incorporation into this
complex (Figs. 9 and 10), presumably due to a higher affin-
ity for the SNAP-25–syntaxin 13 complex (Tsujimoto and
Bean, 2000). Interestingly, the second coiled coil of Hrs has
homology with the SNARE domain and contains Gln at the
ionic 0 layer, suggesting that Hrs–SNAP-25–syntaxin 13
may form a four-helical bundle consisting of Q-SNAREs. 
Although Hrs can completely inhibit the formation of the
syntaxin 13– SNAP-25–VAMP2 complex, it does not com-
pletely inhibit early endosome fusion. Moreover, BoNT/E
inhibits early endosome fusion to the same extent as Hrs.
These data suggest that either there is a pool of endosomes
whose fusion is independent of the Hrs-regulated, SNAP-25
containing, SNARE complex, or that preformed transcom-
plexes may be resistant to disassociation by Hrs or BoNT/E.
VAMP8/endobrevin, another R-SNARE with a widespread
distribution throughout the endocytic pathway, has been re-
ported to function in the homotypic fusion of both early
and late endosomes (Antonin et al., 2000). However, in the
presence of VAMP8 antibodies, residual fusion of early en-
dosomes is observed, although these antibodies completely
prevented assembly of VAMP8 with Q-SNAREs in an in
vitro assembly assay. Additionally, neurons do not express
VAMP8 (Advani et al., 1998), although early endosomes are
involved in endosomal recycling in neurons, further suggest-
ing the possible involvement of multiple R-SNAREs in early
endosomal fusion.
SNAP-25 is considered a Q-SNARE, predominantly ex-
pressed on the plasma membrane, that is involved in exocy-
tosis (Fasshauer et al., 1998; Sutton et al., 1998; Jahn and
Sudhof, 1999; Lin and Scheller, 2000; Chen and Scheller,
2001). An endosomal localization of SNAP-25 (Tao-Cheng
et al., 2000) and SNAP-23 (Chen and Whiteheart, 1999)
implicate SNAP-25/23 to function in endosome fusion.
Our results are the first to show that SNAP-25 is indeed re-
quired for early endosome fusion. The BoNT/E protease
cleaves the COOH-terminal 26 aa from SNAP-25 rendering
it unable to form a four-helical bundle and, therefore, un-
able to support synaptic vesicle fusion and neurotransmitter
release (Banerjee et al., 1996; Chen et al., 1999; Jahn and
Sudhof, 1999; Lin and Scheller, 2000). Treatment of early
endosomal membranes with BoNT/E inhibited their abil-
ity to fuse. Importantly, addition of the COOH-terminal
coiled-coil domain of SNAP-25 reverses this inhibition.
These data provide clear biochemical evidence for the in-
volvement of SNAP-25 in SNARE complex-driven early en-
dosome fusion.
The role of Hrs in endosomal fusion is not inconsistent
with a hypothesis suggesting that Hrs/Vps27p functions in
endocytic protein sorting (Katzmann et al., 2001; Bilodeau
et al., 2002; Lloyd et al., 2002). These studies have sug-
gested that Vps27p is linked with proteins required for the
ubiquitination and sorting of cargo (Katzmann et al., 2001;
Bilodeau et al., 2002). These data suggest that Vps27p is lo-
calized to endosomal membranes by virtue of its FYVE do-
main binding to PI(3)P. Upon binding to endosomes,
Vps27p may bind ubiquitin with its ubiquitin interacting
motif (UIM) domain (Bilodeau et al., 2002; Polo et al.,
2002; Shih et al., 2002). The UIM domain of Hrs is re-
quired for the cargo sorting function as mutation of that do-
main in Vps27p or Hrs blocks sorting of ubiquitinated cargo
proteins, whereas other endosomal functions remain intact
(Bilodeau et al., 2002; Shih et al., 2002). The endosomal
sorting function has also been hypothesized to require a pro-
tein complex called ESCRT I (Katzmann et al., 2001). Hrs
has been suggested to recruit the ESCRT 1 complex to early
endosomes. Thus, Hrs-deficient endosomes probably fail to
form intraluminal vesicles (Lloyd et al., 2002) because of the
inability of Hrs-deficient endosomes to recruit ESCRT-I.
The role of Hrs in recruiting sorting or signaling compo-
nents to the endosomal membrane likely is a function of a
number of factors including its phosphorylation and/or
competition among binding proteins. Therefore, Hrs may
bind to SNAP-25 using its Q-SNARE domain and inhibit
endosomal fusion (Fig. 10) while it is involved in cargo sort-
ing or endosome motility using NH2-terminal VHS, FYVE,
or UIM domains or via other protein interactions.
Several in vitro systems measuring endosome fusion have
demonstrated that the majority of early endosomes are capa-
ble of fusion (Braell, 1987; Diaz et al., 1988; Gruenberg et
al., 1989; Ward et al., 1990). However, the capability of
early endosomes to fuse in vivo is restricted, suggesting that
there are constraints on endosome association in vivo (Salz-
man and Maxfield, 1988; Ward et al., 1990). Why would itT
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be advantageous to inhibit fusion in situ? Perhaps after sort-
ing cargo into different endosomes permitting them to fuse
would allow the cargo to remix, producing a futile cycle.
This would suggest that a sorting step might occur before, or
coincident with, the inhibition of fusion. Moreover, if endo-
somes were tethered to cytoskeletal elements, the physical
separation and vectorial restriction would provide a barrier
to their interaction. In this regard, an interaction between
Hrs and actinin-4 has been suggested to tether transferrin-
containing early endosomes with actin filaments (unpub-
lished data). This suggests that Hrs may provide a link be-
tween early endosomes and the actin cytoskeleton, as well as
to directly inhibit their fusion (this paper). This dual func-
tion may be advantageous for endosomes that have sorted
their cargo en route to another destination.
Materials and methods
Materials
Hrs was expressed in insect cells as described previously (Tsujimoto et al.,
1999). Syntaxin 13 (a gift of R. Prekeris, University of Colorado Health
Center, Denver, CO) and Syntaxin 7 (a gift of J. Pevsner, Johns Hopkins
University, Baltimore, MD) and Hrs(449–562) were expressed in Escherichia
coli as described previously (Prekeris et al., 1998; Tsujimoto and Bean,
2000; Ward et al., 2000). Cell lysate from cells expressing rab 15 wt or
Q67L were gifts of L. Elferink (University of Texas Medical Branch,
Galveston, TX). The light chain of BoNT/E was expressed in E. coli (a gift of
H. Niemann, Federal Research Center for Vital Diseases, Tubingen, Ger-
many). Antibodies were obtained from the following sources: EEA1 and
Eps15 (Santa Cruz Biotechnology, Inc.), SV2 (a gift of R. Janz, The Univer-
sity of Texas Health Science Center, Houston, TX), syntaxin 13 (a gift of
R. Prekeris), SNAP-25 (Bean et al., 1997), synaptophysin (Boehringer),
VAMP2, rab 7, and synaptotagmin (Transduction Labs), and syntaxin 6
(StressGen Biotechnologies).
Time course of EGF uptake
HeLa cells were cultured in Dulbecco’s minimum essential medium
(DMEM) containing 5% FBS on coverslips and starved for 1 h in DMEM
containing 1% BSA. Cells were treated with 0.4  g/ml EGF-TMR for vari-
ous times. At each time point, cells were washed with ice-cold PBS, acid
washed (0.2 M glycine and 0.15 M NaCl) and again with ice-cold PBS,
fixed with 4% PFA (10 min), and washed three times with ice-cold PBS.
Cells were labeled with antibodies to EEA1 (early endosomes), rab 7 (late
endosomes), and LAMP 1/2 (lysosomes).
To determine the length of uptake time necessary to label early endo-
somes, we incubated cells with EGF-TMR for 5, 10, 15, 20, and 30 min,
fixed the cells, and labeled with anti-EEA1 antibody (1:100). We deter-
mined that 15 min was optimal for early endosome labeling (Results) and
used this as the pulse time for labeling late endosomes and lysosomes.
Thus, a 15-min pulse of EGF-TMR was applied and chased with DMEM
containing 1% BSA for various times (0, 5, 10, 15, 20, 25, 30, 35, or 45
min) before fixation with 4% PFA.
We determined the optimal labeling time for early endosomes, late
endosomes, and lysosomes by comparing the EGF-TMR labeling to that
of compartment markers. Fixed cells were incubated with primary anti-
bodies overnight at 4 C, and then with secondary antibodies conjugated
to Alexa488 for 30 min at 37 C. After three washes with PBS, coverslips
were mounted with antifade medium (1 mg/ml paraphenylamine di-
amine in 50% glycerol/PBS, pH 8.0). Images of internalized EGF-TMR
and markers of early, late endosomes, and lysosomes were obtained us-
ing an Axiovert microscope (Carl Zeiss MicroImaging, Inc.) with a CCD
camera (model ORCA; Hamamatsu) and optimized with MetaMorph
software (Universal Imaging Corp.). Data were analyzed by first selecting
threshold values for red and green signals, ensuring that colocalization of
the like fluorophores was observed after thresholding. Subsequently, pos-
itive (nonbackground) pixels from red and green images were compared
allowing determination of the overlap between green and red pixels.
Data are presented as arbitrary units of colocalization that correspond to
the percent overlap of red and green pixels at different time points after a
15-min pulse of TMR-labeled EGF. (Fig. 1) The data presented are repre-
sentative of 10 experiments.
Cell-free fusion assay
HeLa cells were grown on 60-mm plates in DMEM containing 5% FBS and
starved for 1 h (DMEM containing 1% BSA) before incubation (15 min at
37 C) with either EGF-488 or EGF-TMR. After washing and chasing for 0,
10, or 30 min, cells were harvested by scraping and centrifuged at 800 g
for 5 min. Cells were resuspended in homogenization buffer (150  l con-
taining 20 mM Hepes 7.4, 0.25 M sucrose, 2 mM EGTA, 2 mM EDTA, and
0.1 mM DTT) and homogenized by passage of the cell suspension 30
times through a 30-gauge needle. Membranes were collected by centrifu-
gation (15,000 g for 10 min), and the resulting supernatant was further sub-
jected to centrifugation at 100,000 g for 10 min to yield a crude endo-
somal fraction. The pellet was resuspended in homogenization buffer
(150  l).
In the complete fusion reaction, donor membranes isolated from cells
incubated with EGF-488 and acceptor membranes isolated from cells in-
cubated with EGF-TMR were mixed on ice. The reactions (total volume 66
 l) also contained rat brain cytosol (15  l, 6.9 mg/ml protein stock), an
ATP regenerating system (2 mM MgATP, 50  g/ml creatine kinase, 8 mM
phosphocreatine, and 1 mM DTT, final concentrations), and PEG 3350
(3.8%). The complete homotypic fusion reactions were incubated at 37 C
for various times (0, 5, 10, 15, 30, 45, 60, 75, 90, and 120 min) to deter-
mine the optimal fusion time (n   6). Other control conditions included
reactions in the absence of donor or acceptor membranes, the ATP regen-
erating system, cytosol, or incubation on ice instead of 37 C (n   21). We
observed that PEG 3350 is neither required for endosome fusion to occur
nor necessary for Hrs inhibition of early endosome fusion. The effect of de-
tergent on the fusion reaction was determined by incubating the fusion re-
actions in reaction buffer containing 1% Triton X-100 for 10 min after the
reaction was completed. To examine the dilution sensitivity of the fusion
reactions, all reactions were performed with constant amounts of donor
and acceptor membranes, constant concentrations of ATP (plus regenera-
tion components), and cytosol while the total reaction volume was in-
creased one-, two-, four-, and eightfold (n   9). All reactions were stopped
on ice by the addition of 550  l ice-cold PBS. The fluorescence in the en-
tire reaction was quantified using a fluorimeter (PTI, Inc.). The excitation
slit (2 nm) and the emission slits (4 nm) remained constant after optimiza-
tion for best signal/noise. Data were acquired using the Felix software pro-
gram (PTI, Inc.) and a single quartz cuvette by exciting samples at 495 nm
and collecting emissions at 519 and 580 nm. We observed that the emis-
sion of Alexa488 at 580 nm contributes  5% to the signal observed. Each
sample was measured by sampling fluorescence at one data point per sec-
ond for 10 s. Data are presented as a percentage of 580-nm signal ob-
tained for a complete homotypic fusion reaction done in parallel for every
experiment.
Expression and purification of fusion proteins
The His-tagged full-length Hrs, Hrs(1–449) and His-tagged BoNT/E light chain
fusion proteins, and all other GST fusion proteins including syntaxin 13,
syntaxin 7, VAMP2, SNAP-25, and Hrs(449–562) were prepared as described
previously (Tsujimoto and Bean, 2000). We previously named our rat
clone of Hrs, Hrs-2, because it was longer than the original mouse Hrs
clone (Komada and Kitamura, 1995; Bean et al., 1997). We have reexam-
ined our clones and we find a sequencing error in the original paper add-
ing  150 aa to the COOH-terminal end of the protein. Thus, the name
Hrs-2 is a misnomer and, to our knowledge, there are no other isoforms of
the Hrs protein. Importantly, this does not alter any of our conclusions or
data from any published work as we have been using the same rat clones
all along. His-tagged proteins were eluted in a batch format using 500 mM
imidazole in PBST (PBS and 0.05% Tween 20). GST fusion proteins were
cleaved from the GST moiety using thrombin (7.5 U/ml; Amersham Bio-
sciences) in a buffer containing 50 mM Tris, pH 8.0, 150 mM NaCl, 2.5
mM CaCl2, and 0.1%  -mercaptoethanol. The cleavage reaction was
stopped after end-over-end incubation at room temperature for 1 h (syn-
taxin 7), 2 h (VAMP2), or 4 h (SNAP-25) by the addition of 0.1 mM PMSF.
His-tagged proteins were concentrated in concentrators (model YM30;
Amicon) and resuspended in reaction buffer. Protein concentrations were
estimated by comparing Coomassie blue staining of bands on SDS-PAGE
gels against a BSA standard.
Effect of Hrs and other proteins on endosomal fusion
To examine the effect of Hrs on endosomal fusion, varying concentrations
of recombinant Hrs (from 0 to 545 nM) were added to complete early en-
dosome, late endosome, and lysosomal fusion reactions (n   12). All reac-
tions were incubated on ice for 15 min and further incubated at 37 C for
60 min. To examine at what stage of the fusion reaction Hrs was able to in-
hibit fusion, a constant concentration of Hrs (180 nM) was added (15 minT
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on ice) to complete fusion reactions at various time points (0, 5, 10, 15,
30, and 60 min) after the reactions had begun, and then transferred to 37 C
for a total incubation time of 60 min (n   6). Proteins that have been previ-
ously examined using other fusion assays were examined in our assay by
incubating the recombinant soluble fragments of syntaxin 13 (n   3), syn-
taxin 7 (n   9), or cell lysates from cells overexpressing wild-type rab 15 or
mutants (Q67L or K46L; n   3) on homotypic fusion reactions with the
complete fusion reactions on ice for 15 min and at 37 C for 60 min.
To identify the domain of Hrs responsible for the inhibition by Hrs on
early endosome fusion, various concentrations of recombinant proteins
full-length Hrs, Hrs(449–562), Hrs(515–562) (0–545 nM), and Hrs(1–449) (0–180
nM) were added to complete early endosome fusion reactions on ice for
15 min and at 37 C for 60 min. The experiments presented are representa-
tive of 12 such determinations (Fig. 5).
Electron microscopy
Donor compartments or complete fusion reactions were fixed with 3%
glutaraldehyde and washed three times in cacodylate buffer. Pellets were
embedded in epon and sections were cut and viewed on a microscope
(model 1010; Jeol). Images were captured directly with a camera (model
Orca; Hamamatsu).
BoNT/E treatment
After isolating the early endosomal vesicles as described above, pellets
were resuspended with 40  l of varying concentrations of BoNT/E (from 0
to 400 nM) and incubated at 37 C for 30 min. Membranes were collected
by centrifugation (100,000 g for 10 min) and resuspended in 100  l of ho-
mogenization buffer for the fusion reactions. After BoNT/E treatment, the
membranes were washed once in reaction buffer and resuspended in 50  l
of reaction buffer containing either no SNAP-25(150–206) or various concen-
trations of SNAP-25(150–206) and incubated for 30 min at 37 C. Membranes
were isolated again by centrifugation and pellets were resuspended in re-
action buffer before assembling fusion reactions as described above. The
experiments presented are representative of nine such experiments (Fig. 8).
Binding of Hrs to membranes
Endosomal membranes were purified from HeLa cells by centrifugation on
a discontinuous sucrose gradient. In brief, one 10-cm plate ( 80% conflu-
ent) was scraped in homogenization buffer (20 mM Hepes, pH 7.4, 0.25 M
sucrose, 2 mM EGTA, 2 mM EDTA, 0.1 mM DTT, 0.4 ml total vol) and
passed through a 30-gauge needle 30 times. The resulting lysate was cen-
trifuged (100,000 g 10 min) and resuspended in 0.17 ml of homogeniza-
tion buffer that was mixed with 61% sucrose to a final concentration of
46% sucrose (0.5 ml total). The 46% sucrose cushion was overlaid with
two additional layers of sucrose 35% (0.65 ml) and 30% (0.45 ml) and
with 0.4 ml of homogenization buffer. The gradients were subjected to
centrifugation in a rotor (model TLS55; Beckman Coulter; 124,000 g for 60
min) and the early endosomes (interface between 30 and 35% sucrose,
EEA-1 positive, and rab 7 negative by Western analysis) and late endo-
somes (upper part of 30%) were isolated. His-tagged Hrs or Myc-tagged
Hrs(449–562) were added to reactions containing purified endosomal mem-
branes in the presence and absence of SNAP-25(150–206) and incubated at
37 C for 60 min. Reactions were stopped by centrifugation (100,000 g for
10 min), and the amount of His-Hrs or myc-Hrs(449–562) was determined in
pellet and supernatant fractions by quantitative Western blotting using
anti-His or anti-myc antibodies. The experiment shown is representative of
10 such experiments (Fig. 6).
Affinity chromatography with Hrs(449–562)
20 rat brains ( 18 g) per column were homogenized with eight strokes of
a homogenizer (Dounce) in buffer A (20 mM Tris-HCl, pH 8.0, 0.1 M KCl,
250 mM sucrose, 2 mM MgCl2, 1 mM DTT, and 1 mM PMSF; Sollner et
al., 1993). The pellet resulting from centrifugation (SW28 rotor; Beckman
Coulter; 60 min at 27,900 rpm) was washed once in buffer B (10 mM
Hepes-KOH, pH 7.8, 100 mM KCl, 2 mM MgCl2, and 1 mM DTT) and re-
suspended in 40 ml of buffer B with the addition of 4% (vol/vol) Triton
X-100, and the suspension was incubated on ice with frequent mixing for
60 min. The lysate was centrifuged again (SW28 rotor 60 min at 27,900
rpm) and the supernatant was dialyzed overnight in buffer C (25 mM Tris-
HCl, pH 7.8, 50 mM KCl, 1 mM DTT, 1% Triton). After dialysis, the lysate
was centrifuged (SW28 rotor 60 min at 27,900 rpm) and the resulting super-
natant was incubated with immobilized GST-Hrs(449–562) or immobilized GST
(control) in buffer D (20 mM Hepes-KCl, pH 7.0, 0.5% Triton X-100, 100
mM KCl, 1 mM DTT, and 2 mM EDTA) for 60 min at 4 C. After washing
with 20 volumes of buffer D, proteins were eluted with three volumes of 1.5
M NaCl in buffer D. Eluted proteins were TCA precipitated, separated by
SDS-PAGE, and subjected to Western blotting using various antibodies. The
experiment presented is representative of 18 such experiments (Fig. 7).
Western blotting
Proteins were resolved on SDS–polyacrylamide gels (12–17% acrylamide)
and transferred to nitrocellulose. Blots were stained with Ponceau S to en-
sure accuracy of protein loading, blocked in blotto (5% dry milk in PBS),
and incubated with primary antibody diluted in blotto. The following anti-
bodies were used for detection of transferred proteins: 6  histidine
(1:1,000; Sigma-Aldrich), anti-EEA1 (1:1,000; Transduction Laboratories),
anti–SNAP-25 (1:1,000; Sternberger Antibodies), anti–syntaxin 13 (1:1,000),
SV2 (1:1,000), and anti-VAMP2 (1:1,000, CHEMICON International, Inc.).
Filters were washed, and antibody labeling was visualized using HRP-con-
jugated secondary antibody and chemiluminescence (Pierce Chemical
Co.), or 
125I-conjugated secondary antibody and phosphorimaging (Molec-
ular Dynamics).
In vitro protein binding
A constant amount of immobilized GST–syntaxin 13 (2  g/reaction) was
incubated with constant amount of SNAP-25 (2  g), VAMP2 (2  g), and
varying amounts of Hrs (from 0 to 6  g) in PBS binding buffer to a final re-
action volume of 30  l. After an end-over-end incubation at 4 C for 1 h,
samples were washed three times with 150  l of binding buffer, solubi-
lized in SDS sample buffer, resolved by SDS-PAGE, and subjected to im-
munoblot analysis using anti-Hrs and anti-VAMP2 antibodies followed by
appropriate 
125I-secondary antibodies. Immunoreactive bands were visual-
ized and quantitated using phosphorimaging. The experiment shown is
representative of seven such experiments (Fig. 9).
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